About Craig Nemiroff
Craig Nemiroff is a managing director, MAK capital at Trailhead Biosystems.
Form D filings also name Craig Nemiroff as a board member at Noveome Biotherapeutics.
Craig Nemiroff first appears on SEC filings in 2023.
Experience
This experience comes from Craig Nemiroff's profile and from SEC filings. For roles taken from filings, the years are when the filings name Craig Nemiroff in the role, so the role may have started earlier or lasted longer.
Trailhead Biosystems Inc. Current
Managing Director, MAK Capital
Member Board of Directors (2024 – Present)
2024 – Present · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
MA
MARAbio Current
Member Board of Directors
2024 – Present
Noveome Biotherapeutics, Inc. Current
Board Member
Member Board of Directors (2023 – Present)
2023 – Present · Pittsburgh, PA
Develops experimental biologic treatments for infants with a serious intestinal disease and other patients.
MF
MAK Capital Fund Current
Analyst
2016 – Present
OP
One East Partners
Analyst
2011 – 2015
PM
Paige Capital Management
Analyst
2008 – 2010
MI
MRU Holdings, Inc.
Vice President of Business Development
2007 – 2008
CC
Capital One Financial Corp
Manager, Corporate Development
2002 – 2006
TG
The Boston Consulting Group
Consultant
2000 – 2002
DL
Davis Polk & Wardwell LLP
Associate
1996 – 1999
Key Colleagues at Startups
The people Craig Nemiroff works with at each company, as listed on that company's latest Form D.
Noveome Biotherapeutics, Inc. · Form D, Aug 27, 2026
Michael Kaufman
Director
HH
Houman Hemmati
Board Member
EK
Eric Keller
Board Member/President
Ronald Poropatich
Board Member/Chairman of the Board
RL
Robert Langer
Director
Patrick Welch
CEO/Board Member
Larry Brown
Executive officer
Karin Potoka
Chief Medical Officer
Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
HH
Houman Hemmati
Director
Wolfgang Hofmann
Board Member, Trailhead Biosystems
David Llewellyn
President and Chief Executive Officer, director
Joshua Snow
Chief Commercial Officer
Jan Jensen
Board Member, Trailhead Biosystems
Divya Trivedi
Chief Operating Officer
Michael Kaufman
Chief Executive Officer, MAK Capital and director